Literature DB >> 16598646

Elevated carbon dioxide tension as a predictor of subsequent adverse events in infants with bronchopulmonary dysplasia.

Thomas Kovesi1, Adel Abdurahman, Marc Blayney.   

Abstract

Infants with bronchopulmonary dysplasia (BPD) are at risk for numerous complications following discharge from the Neonatal Intensive Care Unit (NICU). Few studies have evaluated risk factors for adverse events (AE). This retrospective study provided an initial evaluation of the use of capillary carbon dioxide (PCO2) tension as a predictor of infants with BPD at increased risk for AE. PCO2 was compared in patients who suffered, or avoided, severe AE, defined as pulmonary hypertension, death, or subsequent reintubation or tracheostomy for respiratory illness. One hundred twelve consecutive patients followed at the BPD clinic were evaluated, and data from 104 subjects were suitable for analysis. Mean PCO2, obtained shortly before or after discharge from NICU, was 47.2 mmHg (range, 31-83). PCO2 was significantly higher in patients who required reintubation and ventilation (54.7 vs. 46.7, p < 0.04). No cutoff value of PCO2 clearly distinguished patients with subsequent AE. PCO2 was not significantly higher in the group of patients who had a severe AE than in the group of patients who did not have a severe AE, but logistic regression showed a significant association between PCO2 and risk of both severe AE (p = 0.018), and readmission to hospital (p = 0.038). An elevated PCO2 is associated with an increased risk of AE, including reintubation, and readmission to hospital, in infants with BPD. Patients with an elevated discharge PCO2 may require closer monitoring during followup. Prospective studies will be needed to confirm these observations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16598646     DOI: 10.1007/s00408-005-2556-1

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   3.777


  29 in total

1.  Assessment of pulmonary function in resolving chronic lung disease of prematurity.

Authors:  R Iles; A T Edmunds
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-03       Impact factor: 5.747

2.  Good estimation of arterial carbon dioxide by end-tidal carbon dioxide monitoring in the neonatal intensive care unit.

Authors:  Chia-Hua Wu; Hung-Chieh Chou; Wu-Shiun Hsieh; Wai-Kong Chen; Pei-Yu Huang; Po-Nien Tsao
Journal:  Pediatr Pulmonol       Date:  2003-04

3.  Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period.

Authors:  A T Shennan; M S Dunn; A Ohlsson; K Lennox; E M Hoskins
Journal:  Pediatrics       Date:  1988-10       Impact factor: 7.124

4.  Value of arterialized capillary blood gas analysis in lower respiratory tract infection in childhood.

Authors:  W B Doig
Journal:  Arch Dis Child       Date:  1971-06       Impact factor: 3.791

Review 5.  Bronchopulmonary dysplasia. Unresolved neonatal acute lung injury.

Authors:  H M O'Brodovich; R B Mellins
Journal:  Am Rev Respir Dis       Date:  1985-09

Review 6.  Hiatal hernia and gastroesophageal reflux.

Authors:  T C Jewett; M Siegel
Journal:  J Pediatr Gastroenterol Nutr       Date:  1984-06       Impact factor: 2.839

7.  Clinical and roentgenographic scoring systems for assessing bronchopulmonary dysplasia.

Authors:  S S Toce; P M Farrell; L A Leavitt; D P Samuels; D K Edwards
Journal:  Am J Dis Child       Date:  1984-06

8.  Prediction of early outcome in resolving chronic lung disease of prematurity after discharge from hospital.

Authors:  R Iles; A T Edmunds
Journal:  Arch Dis Child       Date:  1996-04       Impact factor: 3.791

9.  Are infants with bronchopulmonary dysplasia at risk for sudden infant death syndrome?

Authors:  P H Gray; Y Rogers
Journal:  Pediatrics       Date:  1994-05       Impact factor: 7.124

Review 10.  Pathophysiology and treatment of bronchopulmonary dysplasia. Current issues.

Authors:  S H Abman; J R Groothius
Journal:  Pediatr Clin North Am       Date:  1994-04       Impact factor: 3.278

View more
  4 in total

1.  CO2-evoked release of PGE2 modulates sighs and inspiration as demonstrated in brainstem organotypic culture.

Authors:  David Forsberg; Zachi Horn; Evangelia Tserga; Erik Smedler; Gilad Silberberg; Yuri Shvarev; Kai Kaila; Per Uhlén; Eric Herlenius
Journal:  Elife       Date:  2016-07-05       Impact factor: 8.140

2.  Using a home oxygen weaning protocol and pCO2 to evaluate outcomes for infants with bronchopulmonary dysplasia discharged on home oxygen.

Authors:  Sara K Dawson; Lynn A D'Andrea; Ryan Lau; Joanne M Lagatta
Journal:  Pediatr Pulmonol       Date:  2020-09-15

Review 3.  Etiology, diagnosis, and pharmacologic treatment of pediatric pulmonary hypertension.

Authors:  Robert Tulloh
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

4.  Utility of echocardiography in predicting mortality in infants with severe bronchopulmonary dysplasia.

Authors:  Shilpa Vyas-Read; Erica M Wymore; Isabella Zaniletti; Karna Murthy; Michael A Padula; William E Truog; William A Engle; Rashmin C Savani; Sushmita Yallapragada; J Wells Logan; Huayan Zhang; Erik B Hysinger; Theresa R Grover; Girija Natarajan; Leif D Nelin; Nicolas F M Porta; Karin P Potoka; Robert DiGeronimo; Joanne M Lagatta
Journal:  J Perinatol       Date:  2019-09-30       Impact factor: 2.521

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.